News und Analysen
Premier Inc. to Report Fiscal 2020 Third-Quarter Results and Host Conference Call Before Market Opens on May 5
Premier Inc. (NASDAQ: PINC) plans to report fiscal 2020 third-quarter financial results the morning of May 5, 2020, followed by a conference call at 8 a.m. ET to discuss the results.
Conference
Premier Inc. Real-Time Technology Solution Tracks, Manages and Supports Treatment of COVID-19 Patients Across the Country
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is marshaling all its data and technology capabilities to provide real-time, integrated solutions that help make it easier for
Premier Inc. Survey: Isolation Gowns Replace N95 Masks as the Top Shortage Concern Among Hospitals and Health Systems Treating COVID-19 Patients
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that isolation gowns surpassed N95 masks as the top personal protective equipment (PPE)
As COVID-19 Pushes Hospital Patients to Post-Acute Care Settings, Supply and Resource Needs Grow, Per Premier Inc. Survey
Senior nursing and assisted living facilities have limited personal protective equipment (PPE) to care for a greater volume of patients, according to a Premier Inc. survey – indicating a second
Novocure Provides Business Update Related to COVID-19
Novocure (NASDAQ: NVCR) today provided an update on its response to the global COVID-19 pandemic and an initial evaluation of the impact the pandemic may have on Novocure’s general business
Premier Inc. Pursues Crucial Strategies to Get Supplies, Enable Care Delivery During COVID-19
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is coordinating across the industry to help solve the supply chain challenges presented by COVID-19. Success will rely on
Premier Inc. Survey: As COVID-19 Spreads to New Hotspots, Hospitals Should Prepare for up to a 17X Surge in Supply Demand
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results quantifying the surge capacity needed for personal protective equipment (PPE) and other supplies
Premier Inc. Data Shows Drugs Essential to Providing Care for COVID-19 Patients Quickly Slipping into Shortage
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released data finding that 15 drugs essential to providing care for COVID-19 patients are currently in or very near
Gemeinsamer Bundesausschuss beschließt Aufnahme von TTFields in die Richtlinie Methoden Vertragsärztlicher Versorgung (MVV-RL)
Novocure (NASDAQ: NVCR) gab heute bekannt, dass der Gemeinsame Bundesausschuss (G-BA) die Ergänzung der MVV-RL um die Methode Tumortherapiefelder (TTFields) beschlossen hat. Optune ist somit für
Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend™ XmAb® Antibody Technology in Investigational Antibodies to Treat COVID-19
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced it has entered
German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany
Novocure (NASDAQ: NVCR) today announced that the German Federal Joint Committee, or G-BA, has updated its directive for Contracted Medical Care to include Tumor Treating Fields, establishing
Novocure Announces Optune Lua™ as the Brand Name for the NovoTTF-100L™ System
Novocure (NASDAQ: NVCR) announced today that Optune Lua is the brand name for the NovoTTF-100L System in malignant pleural mesothelioma (MPM). The U.S. Food and Drug Administration (FDA) previously
Premier Inc. Survey: More Than Two-Thirds of Senior Living Facilities Say They Can’t Access Personal Protective Equipment Needed for COVID-19 Containment Plans
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released survey results finding that more than two-thirds of senior living facilities in the United States cannot obtain
Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy
Novocure (NASDAQ: NVCR) announced today that preclinical data on Tumor Treating Fields in combination with anti-PD-1 therapy were published in the peer-reviewed journal, Cancer Immunology,
Premier Inc. Survey Finds 86 Percent of Health Systems Are Concerned About Personal Protective Equipment Shortages Due to Coronavirus
Premier Inc. (NASDAQ: PINC) today released survey results finding that 86 percent of U.S. hospitals and health systems are concerned about their supply of face masks and other personal protective
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the quarter and year ended December 31, 2019, highlighting continued commercial execution, strengthening financial performance and
Healthcare Improvement Company Premier Inc. to Present at Raymond James 41st Annual Institutional Investors Conference in Orlando on March 3
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that its CEO, Susan DeVore, and Chief Administrative and Financial Officer, Craig McKasson, will present at
Premier Inc. Celebrates a Year of Success in Eliminating Drug Shortages
Premier Inc. (NASDAQ: PINC) today released an annual report on its national drug shortage programs, detailing key accomplishments and successful outcomes that have been achieved in collaboration
Premier Inc. Named One of the 2020 World’s Most Ethical Companies® by Ethisphere® Institute for the 13th Year in a Row
Premier Inc., a leading healthcare improvement company, has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2020
Xencor Reports Fourth Quarter and Full Year 2019 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported financial
Premier Inc. ProvideGx™ Program Partners with Pfizer Inc. to Provide Corvert® and Vincristine to Providers
Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Pfizer Inc. to supply Corvert® (ibutilide fumarate injection) and Vincristine Sulfate Injection, USP, to healthcare
Medicare ACOs in Premier Inc. Collaborative Outperform Peers in Shared Savings by 21 Percent
Medicare Accountable Care Organizations (ACOs) participating in the Premier Inc. (NASDAQ: PINC) Population Health Management Collaborative (PHMC) have outperformed their peers by 21 percent in
Xencor to Host Fourth Quarter and Full Year 2019 Financial Results Webcast and Conference Call on February 24, 2020
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that it will
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that company
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development of Next-Generation Food Allergy Treatments
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, announced it has granted an